Pacer BioThreat Strategy ETF (VIRS): Price and Financial Metrics ETF

Pacer BioThreat Strategy ETF (VIRS): $40.03

0.01 (+0.02%)

POWR Rating

Component Grades

Buy & Hold

NR

Peer

NR

Add VIRS to Watchlist
Sign Up

Category: Large Cap Blend ETFs

Category

C

Ranked

Unranked

in category

VIRS Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market

Current price $40.03 52-week high $40.03
Prev. close $40.01 52-week low $27.78
Day low $40.00 Volume 1,900
Day high $40.03 Avg. volume 237
50-day MA $38.90 Dividend yield 0.83%
200-day MA $36.15

VIRS Stock Price Chart Interactive Chart >


Pacer BioThreat Strategy ETF (VIRS) ETF Bio


The investment seeks to track the performance, before fees and expenses, of the LifeSci BioThreat Strategy Index (the index). Under normal circumstances, at least 80% of the funds total assets (exclusive of collateral held from securities lending) will be invested in the component securities of the index. The index is generally composed of U.S.-listed stocks of companies whose products or services help protect against, endure, or recover from biological threats to human health. It is non-diversified.

VIRS ETF Info

Issuer Pacer Financial
Expense Ratio 0.7%
Underlying Index LifeSci BioThreat Strategy Index
Asset Class Equity
Sector Large Cap Blend ETFs
Assets Under Management (AUM) 4.00M
Net Asset Value (NAV) $40.03
Options? Yes
Total Holdings 1000

VIRS Top Holdings

Symbol Company % of Total
ADSK Autodesk Inc 10.95%
APP AppLovin Corp 7.93%
CRM Salesforce Inc 6.29%
PRLB Proto Labs Inc 6.24%
LULU Lululemon Athletica Inc 6.19%
BKNG Booking Holdings Inc 6.01%
ASML ASML Holding NV 5.59%
DSY Dassault Systemes SE 5.47%
SSYS Stratasys Ltd 5.03%

VIRS Price Returns

1-mo N/A
3-mo 0.55%
6-mo 8.27%
1-year 25.72%
3-year 20.24%
5-year N/A
YTD 24.72%
2023 15.67%
2022 -18.02%
2021 25.50%
2020 N/A
2019 N/A

VIRS Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full VIRS Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!